Abiopharma

🔍 Piper Sarah (Executive)

Company: MCCORMICK & CO INC (MKC)

Report Date: 2026-07-20

Detailed Transactions and Holdings:

• Acquired 21 shares of Common Stock - Voting at $52.22 per share (Direct)
  Date: 2026-07-20 | Code: J | equity_swap_involved: 0 | shares_owned_after: 9,058.46 | transaction_form_type: 5 | Footnotes: F1
• Acquired 43 shares of Phantom Stock (Derivative)
  Date: 2026-07-20 | Code: J | equity_swap_involved: 0 | shares_owned_after: 4,892.21 | transaction_form_type: 5 | Footnotes: F1, F1, F1
• Acquired 45 shares of Phantom Stock (Derivative)
  Date: 2026-08-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 4,937.38 | transaction_form_type: 4 | Footnotes: F2, F2, F2

Footnotes:

• F1: Dividend Reinvestment
• F2: Each share of phantom stock represents the right to receive one share of Common Stock - Voting. Shares of Phantom Stock are payable in shares of Common Stock - Voting in accordance with the terms of the Non-Qualified Retirement Savings Plan.